articleTop 1% cited

Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series

European Radiology · 2006 · Vol. 17(3) · pp. 684–692

Dongil Choi✉(Samsung Medical Center)Hyo Keun Lim(Sungkyunkwan University)Hyunchul Rhim(Sungkyunkwan University)Youngsun Kim(Samsung Medical Center)Won Jae Lee(Samsung Medical Center)Seung Woon Paik(Sungkyunkwan University)Kwang Cheol Koh(Sungkyunkwan University)Joon Hyoek Lee(Samsung Medical Center)Moon Seok Choi(Samsung Medical Center)Byung Chul Yoo(Sungkyunkwan University)

View via DOI Publisher page

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Cholangiocarcinoma and Gallbladder Cancer StudiesMedicineHepatocellular carcinomaRadiofrequency ablationPercutaneousStage (stratigraphy)Proportional hazards modelCirrhosisSurvival rateSurvival analysisSurgery

MeSH terms

AdultAgedAged, 80 and overFemaleFollow-Up StudiesCarcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsMaleMiddle AgedNeoplasm StagingPostoperative ComplicationsPrognosisSurvival Rate

Citations

323

FWCI

13.17

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma